Evidence map›Paper›PMID 38175413›Full record

ArticleApplied biochemistry and biotechnology2024

Biosynthesis of Zinc Oxide Nanoparticles Using Bacillus paramycoides for In Vitro Biological Activities and In Vivo Assessment Against Hepatorenal Injury Induced by CCl

Heba A El-Refai, Alaa M Saleh, Shimaa I A Mohamed, Asmaa F Aboul Naser, Rania A Zaki, Sanaa K Gomaa, Manal A Hamed

Abstract read
In one paragraph

Article in Applied biochemistry and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Heba A El-RefaiChemistry of Natural and Microbial Products Department, National Research Centre, Dokki, Giza, Egypt.
Alaa M SalehChemistry of Natural and Microbial Products Department, National Research Centre, Dokki, Giza, Egypt.
Shimaa I A MohamedChemistry of Natural and Microbial Products Department, National Research Centre, Dokki, Giza, Egypt.
Asmaa F Aboul NaserDepartment of Therapeutic Chemistry, National Research Centre, Dokki, Giza, Egypt.
Rania A ZakiChemistry of Natural and Microbial Products Department, National Research Centre, Dokki, Giza, Egypt.
Sanaa K GomaaChemistry of Natural and Microbial Products Department, National Research Centre, Dokki, Giza, Egypt.
Manal A HamedDepartment of Therapeutic Chemistry, National Research Centre, Dokki, Giza, Egypt. manal_hamed@yahoo.com.ORCID http://orcid.org/0000-0003-3643-5842

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, impressive developments in the field of nanotechnology have been achieved. The study aimed to synthetize zinc oxide nanoparticles (ZnONPs) from locally isolated terrestrial Bacillus paramycoides (MCCC 1A04098) bacteria and assess its role as antioxidant, antimicrobial, and anticancer agent. The antioxidant activity was done using the percentage of DPPH scavenging method. The antibacterial activity was evaluated against Escherichia coli, Staphylococcus aureus, Bacillus cereus, and Candida albicans. The anti-proliferation assay against hepatocellular carcinoma (HepG2) and human breast cancer (MCF-7) cell lines was estimated by neutral red assay. The apoptotic effect of ZnONP was measured by flow cytometry. The in vivo evaluation was carried out against hepatorenal injuries induced by carbon tetrachloride (CCl

Indexed as

BacillusCarbon TetrachlorideZinc OxideAnimalsAnti-Bacterial AgentsAntineoplastic AgentsAntioxidantsApoptosisChemical and Drug Induced Liver InjuryHep G2 CellsHumansKidneyLiverMaleMCF-7 CellsMetal NanoparticlesAnti-Bacterial AgentsAntineoplastic AgentsAntioxidantsCarbon TetrachlorideZinc OxideAntibacterialAntioxidantCCl4CytotoxicityHepatorenal injuryZinc oxide nanoparticles

Identifiers

PMID38175413
PMCPMC11604716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.